Clinical Trial Update: Study of Efficacy and Safety of Reinfusion of Tisagenlecleucel in Pediatric and Young Adult Patients With Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating reinfusion of tisagenlecleucel in pediatric and young adult patients with acute lymphoblastic leukemia has been terminated with poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• tisagenlecleucel (tisagenlecleucel)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2022-07-15